Kronox Lab Sciences IPO Soars Over 21%, Signaling Strong Market Entry

Kronox Lab Sciences debuted on the stock market with a significant 21% premium over its issue price of Rs 136. Opening at Rs 165 on BSE and Rs 164.95 on NSE, the company secured a market valuation of Rs 597.37 crore. The IPO was oversubscribed by 117.25 times.

Kronox Lab Sciences marked its stock market debut with an impressive 21% premium over its issue price of Rs 136. This translates to an opening price of Rs 165 on the BSE and Rs 164.95 on the NSE, significantly boosting the company's market valuation to Rs 597.37 crore.

The initial public offering (IPO) of Kronox Lab Sciences saw unprecedented interest, being oversubscribed by 117.25 times by the closing day of bidding. The price range for the offer was set between Rs 129-136 per share.

Headquartered in Vadodara, Kronox Lab Sciences specializes in manufacturing high-purity specialty fine chemicals. With more than 185 products, the company serves a diverse range of industries including pharmaceuticals, nutraceuticals, biotech, and personal care. Kronox exports to over 20 countries and is expanding its manufacturing capabilities with a new plant in Dahej, Gujarat.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)